ANGLE plc (LSE:AGL) — Market Cap & Net Worth
Market Cap & Net Worth: ANGLE plc (AGL)
ANGLE plc (LSE:AGL) has a market capitalization of $94.18K (GBX774.07 Million) as of June 19, 2026. Listed on the LSE stock exchange, this UK-based company holds position #31304 globally and #1130 in its home market, demonstrating a 29.73% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ANGLE plc's stock price GBX2.40 by its total outstanding shares 322528409 (322.53 Million). Review ANGLE plc (AGL) financial obligations to assess the company's total debt and financial obligations.
ANGLE plc Market Cap History: 2015 to 2025
ANGLE plc's market capitalization history from 2015 to 2025. Data shows change from $2.81 Million to $94.18K (-29.58% CAGR).
Index Memberships
ANGLE plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$939.61 Million | 0.01% | #367 of 722 |
Weight: ANGLE plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
ANGLE plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ANGLE plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.14x
ANGLE plc's market cap is 0.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.91 Million | $361.00K | -$4.89 Million | 5.30x | N/A |
| 2017 | $2.18 Million | $498.00K | -$6.57 Million | 4.37x | N/A |
| 2018 | $1.53 Million | $628.00K | -$7.56 Million | 2.44x | N/A |
| 2019 | $2.46 Million | $871.50K | -$11.33 Million | 2.82x | N/A |
| 2019 | $2.46 Million | $678.00K | -$8.94 Million | 3.63x | N/A |
| 2020 | $1.87 Million | $762.00K | -$11.61 Million | 2.46x | N/A |
| 2021 | $4.67 Million | $1.01 Million | -$15.01 Million | 4.61x | N/A |
| 2022 | $1.98 Million | $1.04 Million | -$21.69 Million | 1.90x | N/A |
| 2023 | $461.10K | $2.19 Million | -$20.13 Million | 0.21x | N/A |
| 2024 | $402.23K | $2.86 Million | -$14.22 Million | 0.14x | N/A |
Competitor Companies of AGL by Market Capitalization
Companies near ANGLE plc in the global market cap rankings as of June 19, 2026.
Key companies related to ANGLE plc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #131 globally with a market cap of $174.56 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $125.14 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #621 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #664 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #131 | Thermo Fisher Scientific Inc | NYSE:TMO | $174.56 Billion | $464.61 |
| #189 | Danaher Corporation | NYSE:DHR | $125.14 Billion | $177.17 |
| #621 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $562.09 |
| #664 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
ANGLE plc Historical Marketcap From 2015 to 2025
Between 2015 and today, ANGLE plc's market cap moved from $2.81 Million to $ 94.18K, with a yearly change of -29.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | GBX94.18K | -76.59% |
| 2024 | GBX402.23K | -12.77% |
| 2023 | GBX461.10K | -76.73% |
| 2022 | GBX1.98 Million | -57.56% |
| 2021 | GBX4.67 Million | +149.21% |
| 2020 | GBX1.87 Million | -23.84% |
| 2019 | GBX2.46 Million | +60.77% |
| 2018 | GBX1.53 Million | -29.73% |
| 2017 | GBX2.18 Million | +13.85% |
| 2016 | GBX1.91 Million | -31.82% |
| 2015 | GBX2.81 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of ANGLE plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $94.18K USD |
| MoneyControl | $94.18K USD |
| MarketWatch | $94.18K USD |
| marketcap.company | $94.18K USD |
| Reuters | $94.18K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ANGLE plc
ANGLE plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated downstream analysis. It also provides Portrait+ C… Read more